- Home
- XGN vs ICMB Comparison
XGN vs ICMB Comparison
Compare XGN & ICMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XGN
- ICMB
- Stock Information
- Founded
- XGN 2002
- ICMB 2012
- Country
- XGN United States
- ICMB United States
- Employees
- XGN N/A
- ICMB N/A
- Industry
- XGN Medical Specialities
- ICMB Finance: Consumer Services
- Sector
- XGN Health Care
- ICMB Finance
- Exchange
- XGN Nasdaq
- ICMB Nasdaq
- Market Cap
- XGN 49.4M
- ICMB 48.0M
- IPO Year
- XGN 2019
- ICMB N/A
- Fundamental
- Price
- XGN $3.03
- ICMB $3.19
- Analyst Decision
- XGN Buy
- ICMB
- Analyst Count
- XGN 1
- ICMB 0
- Target Price
- XGN $7.00
- ICMB N/A
- AVG Volume (30 Days)
- XGN 33.9K
- ICMB 29.9K
- Earning Date
- XGN 11-11-2024
- ICMB 11-11-2024
- Dividend Yield
- XGN N/A
- ICMB 15.03%
- EPS Growth
- XGN N/A
- ICMB N/A
- EPS
- XGN N/A
- ICMB N/A
- Revenue
- XGN $56,660,000.00
- ICMB $23,878,302.00
- Revenue This Year
- XGN $9.98
- ICMB $10.32
- Revenue Next Year
- XGN $13.63
- ICMB N/A
- P/E Ratio
- XGN N/A
- ICMB N/A
- Revenue Growth
- XGN 7.05
- ICMB N/A
- 52 Week Low
- XGN $1.30
- ICMB $2.98
- 52 Week High
- XGN $3.71
- ICMB $4.12
- Technical
- Relative Strength Index (RSI)
- XGN 53.18
- ICMB 53.71
- Support Level
- XGN $2.90
- ICMB $3.04
- Resistance Level
- XGN $3.18
- ICMB $3.22
- Average True Range (ATR)
- XGN 0.17
- ICMB 0.09
- MACD
- XGN -0.02
- ICMB 0.01
- Stochastic Oscillator
- XGN 65.12
- ICMB 59.08
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
About ICMB Investcorp Credit Management BDC Inc.
Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). Its investment objective is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.